Earnings History Data for Vericel Corporation (VCEL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Vericel Corporation

Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the knee, and Epicel (R) for the treatment of severe burns. It is also developing MACI (TM) for the treatment of cartilage defects in the knee, and ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. Vericel Corporation, formerly Aastrom Biosciences, Inc., is based in United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
29-02-2024 PM VCEL Vericel Corporation 2,290 0.26 0.18 0.12 Vericel GAAP EPS of $0.26 beats by $0.09, revenue of $65M beats by $1.05M
[2/29/2024 8:00 AM]		 45.70 -2.09 
(-4.38%)		 48.54 0.74 
(1.55%)		 27.92 - 50.09 744,419 470,000 865
08-11-2023 PM VCEL Vericel Corporation 1,720 -0.08 -0.13 -0.14 Vericel GAAP EPS of -$0.08 beats by $0.04, revenue of $45.6M beats by $0.45M
[11/8/2023 7:57 AM]		 35.27 -1.24 
(-3.40%)		 35.27 0.0 
(0.00%)		 17.30 - 39.90 402,649 310,000 7,557
02-08-2023 PM VCEL Vericel Corporation 1,710 -0.11 -0.13 -0.19 Vericel beats Q2 top and bottom line estimates; raises FY23 revenue outlook
[8/2/2023 7:58 AM]		 34.71 -0.41 
(-1.17%)		 34.50 -0.62 
(-1.77%)		 17.30 - 39.90 480,057 390,000 5,023
10-05-2023 PM 7:55 AM ET
(May 10)		 VCEL Vericel Corporation 1,570 -0.16 -0.13 -0.15 Vericel GAAP EPS of -$0.16 misses by $0.01, revenue of $41.01M beats by $3.64M
[5/10/2023 7:57 AM]		 34.25 1.41 
(4.29%)		 0.0 0.0 
(0.00%)		 17.30 - 35.46 303,682 280,000 0
23-02-2023 PM 7:55 AM ET
(Feb 23)		 VCEL Vericel Corporation 1,410 0.12 0.01 0.09 Vericel GAAP EPS of $0.12 beats by $0.08, revenue of $52.69M misses by $0.27M
[2/23/2023 7:56 AM]		 30.57 2.05 
(7.19%)		 0.0 0.0 
(0.00%)		 17.30 - 43.97 467,322 330,000 0
09-11-2022 PM 7:55 AM ET
(Nov 9)		 VCEL Vericel Corporation 1,140 -0.14 -0.12 -0.11 Vericel GAAP reports Q3 earnings miss; narrows FY22 guidance range below estimates
[11/9/2022 7:58 AM]		 17.84 -5.21 
(-22.60%)		 22.01 -1.04 
(-4.51%)		 17.30 - 46.30 1,789,118 440,000 842
03-08-2022 PM 7:55 AM ET
(Aug 3)		 VCEL Vericel Corporation 1,330 -0.19 -0.13 -0.08 Vericel GAAP EPS of -$0.19 misses by $0.07, revenue of $37.05M misses by $1.3M
[8/3/2022 7:59 AM]		 31.65 -0.16 
(-0.50%)		 31.81 0.0 
(0.00%)		 22.42 - 60.24 411,677 360,000 5,740
04-05-2022 PM 7:55 AM ET
(May 4)		 VCEL Vericel 1,339 -0.15 -0.15 0.00 Vericel GAAP EPS of -$0.15 misses by $0.03, revenue of $36.07M beats by $1.76M
[5/4/2022 7:58 AM]		 31.11 -0.24 
(-0.78%)		 31.36 0.0 
(0.00%)		 28.39 - 68.94 556,823 550,000 19,772
24-02-2022 PM 7:40 AM ET
(Feb 24)		 VCEL Vericel Corporation 1,560 0.09 0.17 0.25 Vericel GAAP EPS of $0.09 misses by $0.05, revenue of $47.6M misses by $0.49M; initiates FY22 guidance
[2/24/2022 7:58 AM]		 38.65 6.47 
(20.11%)		 0.0 0.0 
(0.00%)		 30.67 - 68.94 836,214 522,077 0
09-11-2021 PM 8:00 AM ET
(Nov 9)		 VCEL Vericel Corporation 2,270 -0.11 -0.03 0.08 Vericel EPS misses by $0.08, misses on revenue
[11/9/2021 7:46 AM]		 42.20 -0.90 
(-2.09%)		 40.00 -3.10 
(-7.19%)		 22.93 - 68.94 631,810 340,000 13,796
04-08-2021 PM 7:00 AM ET
(Aug 4)		 VCEL Vericel Corporation 2,460 -0.08 -0.05 -0.18 Vericel EPS in-line, beats on revenue; raises guidance
[8/4/2021 8:10 AM]		 49.18 -2.54 
(-4.91%)		 49.18 0.0 
(0.00%)		 14.45 - 68.94 873,510 250,000 13,351
05-05-2021 PM 8:00 AM ET
(May 5)		 VCEL Vericel Corporation 2,880 -0.07 -0.06 -0.10 Vericel EPS misses by $0.03, beats on revenue
[5/5/2021 7:07 AM]		 56.59 -2.56 
(-4.33%)		 56.59 0.0 
(0.00%)		 12.82 - 64.89 603,157 490,000 5,432
24-02-2021 PM 8:00 AM ET
(Feb 24)		 VCEL Vericel Corporation 2,200 0.25 0.21 0.20 Vericel EPS beats by $0.05, beats on revenue
[2/24/2021 8:02 AM]		 49.38 2.01 
(4.24%)		 47.37 0.0 
(0.00%)		 6.78 - 53.98 426,982 713,367 697
05-11-2020 PM 8:00 AM ET
(Nov 5)		 VCEL Vericel Corporation 946.64 0.08 -0.03 0.07 Vericel EPS beats by $0.10, beats on revenue
[11/5/2020 8:03 AM]		 21.73 0.53 
(2.50%)		 21.73 0.0 
(0.00%)		 6.78 - 22.26 682,722 404,134 7,413
05-08-2020 PM 8:00 AM ET
(Aug 5)		 VCEL Vericel Corporation 743.87 -0.18 -0.23 -0.05 Vericel EPS beats by $0.02, beats on revenue
[8/5/2020 8:07 AM]		 16.10 -0.72 
(-4.28%)		 16.82 0.0 
(0.00%)		 6.78 - 19.77 284,161 468,252 8,508
05-05-2020 PM 8:00 AM ET
(May 5)		 VCEL Vericel Corporation 629.69 -0.10 -0.09 -0.07 Vericel EPS misses by $0.02, beats on revenue
[5/5/2020 8:02 AM]		 14.77 0.75 
(5.35%)		 14.25 0.23 
(1.64%)		 6.78 - 19.95 203,683 856,193 207